SlideShare a Scribd company logo
Chairperson:
Asst. Prof. Dr. Snehangshu Shekhar Samanta
Presenter : Dr. Arijit Biswas
 Its a generic term used to indicate a
battery of test or manouvers
performed using standardised
equipment to evaluate function of
lung.
1. Tests for ventilatory functions:
 Evaluate lung volumes and capacities:
- Spirometry
- Body Plethysmography
- Gas dilution method
( FRC & RV detection)
 Evaluate hypersensitivity of airway
- Bronco provocation test
2.Tests for gas exchange:
DLCO , ABG, Oxymetry and Capnography.
3. Other Tests:
 Tests for lung compliance.
 Test for resistance and impedence: Impulse oscillometry.
 Assessment of regional lung functions.
 Assessment of respiratory muscle strength.
 Breath condensate.
 Gives the evidence of deranged lung function
 Helps to rule out/ identify resp cause of SOB
 Quantifying lung function in pt undergoing lung resection
 Type of resp failure
 Detects airway hyper responsiveness
 Evaluation of disability
 Course of disease over time
 VOLUME
DISPLACEMENT
SPIROMETER:
 FLOW SENSING
SPIROMETER:

500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
TV= AMOUNT OF GAS GOING IN AND OUT WITH
EACH RESPIRATION
500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
IRV= EXCESS AIR THAT CAN BE BREATHED IN WITH
EXTRA EFFORT AFTER TIDAL INSPIRATION
500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
ERV= EXTRA AMOUNT OF GAS THAT CAN BE BREATHED OUT
WITH EXTRA EFFORT AFTER TIDAL EXPIRATION
500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
RV= AIR LEFT BEHIND AFTER MAX EXPIRATION
500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
FVC= AMOUNT OF AIR THAT CAN BE BREATHED OUT
WITH MAX EFFORT AFTER FORCEFUL INSPIRATION
500ml
4.5l
1.2+1 L 1.2L
1L
4.5+1.2 L
3L
FRC= AMOUNT OF AIR LEFT IN LUNG AFTER NORMAL
TIDAL EXPIRATION
 It can measure:
1. Tidal vol (500ML)
2. IRV (3L)
3. ERV (1L)
4. VC (4.5L)
 What it can not
measure:
1. RV
2. FRC = ERV+ RV
3. TLC = FVC+RV
1.Diagnostic:
A.To evaluate symptoms, signs, and
abnormal lab tests
• Symptoms: dyspnea wheezing, orthopnea, cough, phlegm
production, chest pain
• Signs: diminished breath sound, over inflation, expiratory
slowing, cyanosis, chest deformity, unexplained crackles
• Abnormal lab test: hypoxemia, hypercapnia, abnormal chest
radiograph
B. To measure the effect of disease on
pulmonary function
C. To screen individuals at risk of having
pulmonary disease
 Smokers
 Occupational exposure
D. To assess preop risk
prognosis( lung transplant)
health ststus before begining of a
strenous physical activity program
2. Monitoring
To assess therapeutic intervention
a) Bronchodilator therapy
b) Steroid therapy (Asthma, ILD)
c) Antibiotics in cystic fibrosis
To describe the course of disease that affect lung
function
 Pulmonary disease (obstructive airway disiese,ILD)
 Cardiac disease (CHF)
 NM disorders (GB syndrome)
To monitor people exposed to injurious agent
To monitor adverse reaction to drug with known
pulmonary toxicity
3.To identify Flow Volume Loop patterns
4. Disability/Impairment evaluation
To assess patients as part of rehabilitation
program
To assess risk as a part of an insurance
evaluation
5. Public Health: For clinical research
Due to increased
myocardial
demand
1. AMI within1WK
2. Hypo / severe
hypertension
3. Ventr
arrhythmia /
non
compensated
HF
4. PAH / Acute
corpulmonale
Due to increased
intracranial/intraocul
ar/intrathoracic
pressure
1. Cerebral aneurysm
2. Brain surgery 4wk
3. Eye surgery 1 wk
4. Pneumothorax
5. Thoracic/ abd sx
4wk
6. Late term
pregnancy
Infection controle
issue
1. Active /
transmissable
resp inf
(TB/covid)
2. Hemoptysis
3. Oral lesion/ bleed
Should be discontinued if pt feels pain during procedure
 In pulm funtion lab, where operator are
experienced enough,
 Emergency care can be given if needed
 Callibration of the device
 Quiet and calm env.
 Temp and barometric pressure is a important
variable in PFT
 Smoking within 1 hr
 Consuming intoxicants before 8hr of test
 Vigorous exercise within 1 hr
 Tight clothes that interrupt chest and abd
wall expansion freely
 Seated erect
 Shoulder slightly back, Chin slightly up
 Chair without wheel with height adjustment
 Feet should be flat on the floor
 Nose clip or manual occlusion of nose
should be used
 Test in standing position are more or less
similar to sitting
 Spirometry can be a major source of infection as
well as place of infection transmission
Directly by : Mouthpiece, noseclip, chair arms
Indirectly by : Aerosol droplet generation
Avoide this risks by : Handwashing/sanitisation
Use of disposable
equipment where possible
1. FEV1 and FVC manouver
2. Expiration only manouver
3. Bronchodialator responsive testing
manouver (Reversibility test)
4. SVC (slow vital capacity) manouver
 Equipment must be Calibrated
 Loosen tight fitting clothes
 Denture if they are loose better tobe removed
 Age, Weight, Height is recorded
 Explain the pt about the procedure
 Counsel that the procedure may not be comfortable
Maximum
inspiration
•Start at flow zero
•Inspire as deeply as possible
•No pause
•Wait till the inspiration is complete ( eye brow
becomes widened, head starts quivering)
Blast of
expiration
• Don’t just blow, blow as much and as forcefully
possible
Continued
expiration
At least 6 sec is acceptable
3 sec for <10 yrs
Wait for the plateau phase in display
Ask for the next step
Maximum
inspiration
after forced
expiration
•To return to TLC and complete the flow volume
curve
•This will cross check whether the
pt began exp from full
inspiration or not
FEV1/FVC MANEUVER
Expiration only manouver
(Done for children only)
Inspire maximum lung vol within 2 s
Insert mouth piece
Innitiate max expiration
Remove mouth piece at end of forced expiration
Bronchodialator responsive test
Degree of improvement of air flow in response to bronco
dilator
Can differentiate Asthma from other COPD
But neither asthma nor COPD is diagnosed on
spirometry
bronchodilator Dose FEV1 before and
after
Salbutamol 200-400mcg
via large spacer
15 min
Terbutaline 500 mcg via
turbohaler
15 min
Ipratropium 160 mcg via
spacer
45 min
The test can be concluded
when both ACCEPTABILITY and
REPEATABILITY criteria are met
To ensure the REPRODUCIBILITY of
the test
Requires 5 to maximum 8 attempt
 Free from artefact ( Cough / Early glottis closure)
 Good start
 Free from leaks
 Extrapolation back from the PEFR gives a
theoretical start time (should be within 5% of FVC
or within 150 ml)
 Acceptable exhalation
 Adults :at least 6 sec of exhalation and plateue
 Children <10yrs : at least 3 sec of exhalation
 Three acceptable maneuvers (meeting above
criteria)
 Two largest FVC measurements within 150 ml
of each others
 Two largest FEV1 measurements within
150ml of each others
1. FVC
2. FEV1
3. FEF 25-75
4. Change in FVC and FEV1 after broncho
dialator use
5. Flow volume curve
6. Flow time curve
Flow volume Loop
FEV!
Effort
dependent
part
Effort
independent
part
PEFR
 Total volume of air that
can be exhaled forcefully
from TLC
 The majority of FVC can
be exhaled in<3 seconds
in normal
 Often prolonged in
Obstructive lung disease
 Measured in liters
 80-120% = Normal
 70-79% = Mild
reduction
 50-69% = Moderate
reduction
 <50% = Severe
reduction
 Volume of air forcefully
expired from full
inspiration (TLC) in first
second
 Normally 75-80% of
FVC is exhaled in first
second
 Thus FEV1/FVC can be
utilised to characterise
lung disease
 Mean forced
expiratory flow
during middle half of
FVC
 May reflect effort
independent
expiration And the
status of the small
air way
 >60% normal
 40-60% mild obstruction
 20-40% moderate obstruction
 <20% Severe obstruction
INTERPRETETION
FVC alone does not make any sense unless
and until we compare it with the time
dimension i.e. FEV1
Main determinant of PFT is the FEV1/FVC
FEV1/FVC
(>80%)
LOW Normal/high
Always
obstructive
Restrictive
Obstructive
1. COPD
(Emphysema/
Bronchiectasis/S
AD)
1. ASTHMA
2. CF
3. BRONCHIOLITIS
4. BRONCHIECTASIS
For expiration driving force >Air pressure
Driving force = IPP + Elastic recoil pressure
Elastic recoil pressure is low in obstructive ds
That is why exp function (FVC) starts falling day by day
Hyperinflation Air trapping
FEV1 low Low
FVC normal Low
RV High High
TLC
(FVC+RV)
High Remain unchanged
Obstructive
Q. Can obstr lung dis have normal FEV1/FVC ?
Yes, in Small air way disease.
Here we diagnose SAD by FEF 25-75 /MMEFR/MEAN FORCED
EXPIRATORY FLOW RATE
It is the average flow rate of lung in middle 50% of
the FVC manouver
It is the slope of the line
 Reversibility test by SABA
 If FEV1 > 12%
and
FVC > 200ml
It indicates
Bronchial
Asthma
RVERSIBILITY TEST
 Here lung’s inspiratory function is affected
 So IRV is decreased
 FVC= IRV + TV +ERV = FVC
 FEV1 remains normal more or less
 FEV1/FVC remains normal/high
Flow volume Loop
 Restrictive
Restrictive
Extra
parenchymal
NM disorders
(TLC Low
Chest wall
deformities
Intra
parenchymal
DLCO
normal
DLCO low
KCO
normal
Intra
parenchymal
NM disorder Chest wall
deformity
DLCO LOW NORMAL
TLC LOW LOW NORMAL
RV LOW NORMAL
RV/TLC HIGH NORMAL
KCO
(DLCO/VOL)
NORMAL HIGH
 It uses a small amount of CO to measure gas
exchange across the alveolar membrane
during a 10 sec breath hold.
 CO in exhaled air is analysed to determine
the quantity of CO crossing the membrane
FACTORS INCREASD DLCO DECREASED
DLCO
Thickness of alveolar
membrane
ILD
smoking
Altered
volume/surface area
ratio
Emphysema
Hb available Polycythemia Anaemia
Pregnancy
Blood coming to
capilleris
Pulmonary Hge
Asthma
Left to right shunt
Exercise
Pulmonary vascular
disease
 Diffusion limited gas
 Affinity of Hb for CO is >200 times
 Partial pressure of CO in pulmonary
capillaries rises very slowly
KCO (Diffusion coefficient)= DLCO/
Lung Volume
Normal in ILD
Raised in Extra parencymal disease
Intra
parenchymal
NM disorder Chest wall
deformity
DLCO LOW NORMAL
TLC LOW LOW NORMAL
RV LOW NORMAL
RV/TLC HIGH NORMAL
KCO
(DLCO/VOL)
NORMAL HIGH
Different flow vol loops
NORMAL
Scooped
pattern
Fixed airway
obstruction
Extra thoracic
variable obstruction
Intra thoracic
variable obstr
LEVEL OF OBSTRUCTION
 Narrowing is maximal
in Expiration
 As lesion is intra
thoracic
 Intra thoracic pressure
is maximum in
expiration and lower
than air
 Thus expiratory limb is
flattened
e.g. Tracheomalacia
 Obstruction worsens
in inspiration
 As negative pressure
narrows trachea
 Thus Inspiratory limb
flattens
 E.g extrinsic
compression from
Goiter, LN
 Maximum airflow is
limited to a similar
extent in both
inspiration as well as
expiration
 Both limbs are
affected
 E.g. Tracheal
stenosis, FB
 Most common cause is poor patient technique
Sub optimal inspiration
Sub maximal expiratory effort
Delay in forced expiration
Shortened expiratory time
Air leak around the mouth piece
Poor posture = leaning forward
Subjects must be observed and encouraged through the
procedure
Premature
ending
 Highly dependent on patient compliance and
effort
 Thus FEV1 and FVC may be underestimated
 Not useful for <4years/unconcious/sedated
 Can not measure RV,FRC,TLC
Pulmonary Function Test interpetation ppt
Pulmonary Function Test interpetation ppt
Pulmonary Function Test interpetation ppt
Pulmonary Function Test interpetation ppt
Pulmonary Function Test interpetation ppt

More Related Content

Similar to Pulmonary Function Test interpetation ppt

Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
Chetan Ganteppanavar
 
Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsGamal Agmy
 
Spirometry
SpirometrySpirometry
Spirometry
schenzker
 
pulmonary function tests ppt
pulmonary function tests pptpulmonary function tests ppt
pulmonary function tests ppt
PranatiChavan
 
PULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptxPULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptx
Institute Of Medicine(IOM), TUTH
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleem
TASLEEM ARIF
 
Pulmonary Function Test.ppt
Pulmonary Function Test.pptPulmonary Function Test.ppt
Pulmonary Function Test.pptShama
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
raghu srikanti
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
Ashraf ElAdawy
 
Spirometry
SpirometrySpirometry
Spirometry
DrAnsuman Dash
 
PFT.pptx
PFT.pptxPFT.pptx
Pft
PftPft
Pulmonary Function Test
Pulmonary Function TestPulmonary Function Test
Pulmonary Function Test
Rahul Ap
 
Spirometry
SpirometrySpirometry
Spirometry
Donna Ricotta
 
Pediatric pulmonary function tests
Pediatric pulmonary function testsPediatric pulmonary function tests
Pediatric pulmonary function tests
Maulana Azad Medical College
 
PFT
PFT PFT
Lung fuction tests
Lung fuction tests  Lung fuction tests
Lung fuction tests
Sid Kaithakkoden
 
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONPULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
LincyAsha
 
PFT.pdf
PFT.pdfPFT.pdf
PFT.pdf
sanavora1
 
Asthma 2
Asthma 2Asthma 2
Asthma 2
Amir Mahmoud
 

Similar to Pulmonary Function Test interpetation ppt (20)

Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function tests
 
Spirometry
SpirometrySpirometry
Spirometry
 
pulmonary function tests ppt
pulmonary function tests pptpulmonary function tests ppt
pulmonary function tests ppt
 
PULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptxPULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptx
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleem
 
Pulmonary Function Test.ppt
Pulmonary Function Test.pptPulmonary Function Test.ppt
Pulmonary Function Test.ppt
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
 
Spirometry
SpirometrySpirometry
Spirometry
 
PFT.pptx
PFT.pptxPFT.pptx
PFT.pptx
 
Pft
PftPft
Pft
 
Pulmonary Function Test
Pulmonary Function TestPulmonary Function Test
Pulmonary Function Test
 
Spirometry
SpirometrySpirometry
Spirometry
 
Pediatric pulmonary function tests
Pediatric pulmonary function testsPediatric pulmonary function tests
Pediatric pulmonary function tests
 
PFT
PFT PFT
PFT
 
Lung fuction tests
Lung fuction tests  Lung fuction tests
Lung fuction tests
 
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATIONPULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
PULMONARY FUNCTION TESTS - LAB DATA INTERPRETATION
 
PFT.pdf
PFT.pdfPFT.pdf
PFT.pdf
 
Asthma 2
Asthma 2Asthma 2
Asthma 2
 

More from Murali Krishna

Critical care in post op Respi Patients.pptx
Critical care in post op Respi Patients.pptxCritical care in post op Respi Patients.pptx
Critical care in post op Respi Patients.pptx
Murali Krishna
 
NEUROlogical Tuberculosis management and diagnosis
NEUROlogical Tuberculosis management and diagnosisNEUROlogical Tuberculosis management and diagnosis
NEUROlogical Tuberculosis management and diagnosis
Murali Krishna
 
cornealulcers diagnosis treatment and other factors
cornealulcers diagnosis treatment and other factorscornealulcers diagnosis treatment and other factors
cornealulcers diagnosis treatment and other factors
Murali Krishna
 
OPerational Reaserch-guidelinesfor tbpptx
OPerational Reaserch-guidelinesfor tbpptxOPerational Reaserch-guidelinesfor tbpptx
OPerational Reaserch-guidelinesfor tbpptx
Murali Krishna
 
interventional-bronchoscopy_sachin_2009.pdf
interventional-bronchoscopy_sachin_2009.pdfinterventional-bronchoscopy_sachin_2009.pdf
interventional-bronchoscopy_sachin_2009.pdf
Murali Krishna
 
cap (1).pptx
cap (1).pptxcap (1).pptx
cap (1).pptx
Murali Krishna
 
Murali bronchiectasis.pptx
Murali bronchiectasis.pptxMurali bronchiectasis.pptx
Murali bronchiectasis.pptx
Murali Krishna
 
COPD-Patient-Intervention-Module.ppt
COPD-Patient-Intervention-Module.pptCOPD-Patient-Intervention-Module.ppt
COPD-Patient-Intervention-Module.ppt
Murali Krishna
 
ICS-Ultra LABA in the management of OAD- CME Slides.pptx
ICS-Ultra LABA in the management of OAD- CME Slides.pptxICS-Ultra LABA in the management of OAD- CME Slides.pptx
ICS-Ultra LABA in the management of OAD- CME Slides.pptx
Murali Krishna
 

More from Murali Krishna (9)

Critical care in post op Respi Patients.pptx
Critical care in post op Respi Patients.pptxCritical care in post op Respi Patients.pptx
Critical care in post op Respi Patients.pptx
 
NEUROlogical Tuberculosis management and diagnosis
NEUROlogical Tuberculosis management and diagnosisNEUROlogical Tuberculosis management and diagnosis
NEUROlogical Tuberculosis management and diagnosis
 
cornealulcers diagnosis treatment and other factors
cornealulcers diagnosis treatment and other factorscornealulcers diagnosis treatment and other factors
cornealulcers diagnosis treatment and other factors
 
OPerational Reaserch-guidelinesfor tbpptx
OPerational Reaserch-guidelinesfor tbpptxOPerational Reaserch-guidelinesfor tbpptx
OPerational Reaserch-guidelinesfor tbpptx
 
interventional-bronchoscopy_sachin_2009.pdf
interventional-bronchoscopy_sachin_2009.pdfinterventional-bronchoscopy_sachin_2009.pdf
interventional-bronchoscopy_sachin_2009.pdf
 
cap (1).pptx
cap (1).pptxcap (1).pptx
cap (1).pptx
 
Murali bronchiectasis.pptx
Murali bronchiectasis.pptxMurali bronchiectasis.pptx
Murali bronchiectasis.pptx
 
COPD-Patient-Intervention-Module.ppt
COPD-Patient-Intervention-Module.pptCOPD-Patient-Intervention-Module.ppt
COPD-Patient-Intervention-Module.ppt
 
ICS-Ultra LABA in the management of OAD- CME Slides.pptx
ICS-Ultra LABA in the management of OAD- CME Slides.pptxICS-Ultra LABA in the management of OAD- CME Slides.pptx
ICS-Ultra LABA in the management of OAD- CME Slides.pptx
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 

Pulmonary Function Test interpetation ppt

  • 1. Chairperson: Asst. Prof. Dr. Snehangshu Shekhar Samanta Presenter : Dr. Arijit Biswas
  • 2.  Its a generic term used to indicate a battery of test or manouvers performed using standardised equipment to evaluate function of lung.
  • 3. 1. Tests for ventilatory functions:  Evaluate lung volumes and capacities: - Spirometry - Body Plethysmography - Gas dilution method ( FRC & RV detection)  Evaluate hypersensitivity of airway - Bronco provocation test
  • 4. 2.Tests for gas exchange: DLCO , ABG, Oxymetry and Capnography. 3. Other Tests:  Tests for lung compliance.  Test for resistance and impedence: Impulse oscillometry.  Assessment of regional lung functions.  Assessment of respiratory muscle strength.  Breath condensate.
  • 5.  Gives the evidence of deranged lung function  Helps to rule out/ identify resp cause of SOB  Quantifying lung function in pt undergoing lung resection  Type of resp failure  Detects airway hyper responsiveness  Evaluation of disability  Course of disease over time
  • 6.
  • 8. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L TV= AMOUNT OF GAS GOING IN AND OUT WITH EACH RESPIRATION
  • 9. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L IRV= EXCESS AIR THAT CAN BE BREATHED IN WITH EXTRA EFFORT AFTER TIDAL INSPIRATION
  • 10. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L ERV= EXTRA AMOUNT OF GAS THAT CAN BE BREATHED OUT WITH EXTRA EFFORT AFTER TIDAL EXPIRATION
  • 11. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L RV= AIR LEFT BEHIND AFTER MAX EXPIRATION
  • 12. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L FVC= AMOUNT OF AIR THAT CAN BE BREATHED OUT WITH MAX EFFORT AFTER FORCEFUL INSPIRATION
  • 13. 500ml 4.5l 1.2+1 L 1.2L 1L 4.5+1.2 L 3L FRC= AMOUNT OF AIR LEFT IN LUNG AFTER NORMAL TIDAL EXPIRATION
  • 14.  It can measure: 1. Tidal vol (500ML) 2. IRV (3L) 3. ERV (1L) 4. VC (4.5L)  What it can not measure: 1. RV 2. FRC = ERV+ RV 3. TLC = FVC+RV
  • 15. 1.Diagnostic: A.To evaluate symptoms, signs, and abnormal lab tests • Symptoms: dyspnea wheezing, orthopnea, cough, phlegm production, chest pain • Signs: diminished breath sound, over inflation, expiratory slowing, cyanosis, chest deformity, unexplained crackles • Abnormal lab test: hypoxemia, hypercapnia, abnormal chest radiograph B. To measure the effect of disease on pulmonary function
  • 16. C. To screen individuals at risk of having pulmonary disease  Smokers  Occupational exposure D. To assess preop risk prognosis( lung transplant) health ststus before begining of a strenous physical activity program
  • 17. 2. Monitoring To assess therapeutic intervention a) Bronchodilator therapy b) Steroid therapy (Asthma, ILD) c) Antibiotics in cystic fibrosis To describe the course of disease that affect lung function  Pulmonary disease (obstructive airway disiese,ILD)  Cardiac disease (CHF)  NM disorders (GB syndrome)
  • 18. To monitor people exposed to injurious agent To monitor adverse reaction to drug with known pulmonary toxicity 3.To identify Flow Volume Loop patterns 4. Disability/Impairment evaluation To assess patients as part of rehabilitation program To assess risk as a part of an insurance evaluation 5. Public Health: For clinical research
  • 19. Due to increased myocardial demand 1. AMI within1WK 2. Hypo / severe hypertension 3. Ventr arrhythmia / non compensated HF 4. PAH / Acute corpulmonale Due to increased intracranial/intraocul ar/intrathoracic pressure 1. Cerebral aneurysm 2. Brain surgery 4wk 3. Eye surgery 1 wk 4. Pneumothorax 5. Thoracic/ abd sx 4wk 6. Late term pregnancy Infection controle issue 1. Active / transmissable resp inf (TB/covid) 2. Hemoptysis 3. Oral lesion/ bleed Should be discontinued if pt feels pain during procedure
  • 20.  In pulm funtion lab, where operator are experienced enough,  Emergency care can be given if needed  Callibration of the device  Quiet and calm env.  Temp and barometric pressure is a important variable in PFT
  • 21.  Smoking within 1 hr  Consuming intoxicants before 8hr of test  Vigorous exercise within 1 hr  Tight clothes that interrupt chest and abd wall expansion freely
  • 22.  Seated erect  Shoulder slightly back, Chin slightly up  Chair without wheel with height adjustment  Feet should be flat on the floor  Nose clip or manual occlusion of nose should be used  Test in standing position are more or less similar to sitting
  • 23.  Spirometry can be a major source of infection as well as place of infection transmission Directly by : Mouthpiece, noseclip, chair arms Indirectly by : Aerosol droplet generation Avoide this risks by : Handwashing/sanitisation Use of disposable equipment where possible
  • 24.
  • 25. 1. FEV1 and FVC manouver 2. Expiration only manouver 3. Bronchodialator responsive testing manouver (Reversibility test) 4. SVC (slow vital capacity) manouver
  • 26.  Equipment must be Calibrated  Loosen tight fitting clothes  Denture if they are loose better tobe removed  Age, Weight, Height is recorded  Explain the pt about the procedure  Counsel that the procedure may not be comfortable
  • 27. Maximum inspiration •Start at flow zero •Inspire as deeply as possible •No pause •Wait till the inspiration is complete ( eye brow becomes widened, head starts quivering) Blast of expiration • Don’t just blow, blow as much and as forcefully possible Continued expiration At least 6 sec is acceptable 3 sec for <10 yrs Wait for the plateau phase in display Ask for the next step Maximum inspiration after forced expiration •To return to TLC and complete the flow volume curve •This will cross check whether the pt began exp from full inspiration or not FEV1/FVC MANEUVER
  • 28. Expiration only manouver (Done for children only) Inspire maximum lung vol within 2 s Insert mouth piece Innitiate max expiration Remove mouth piece at end of forced expiration
  • 29. Bronchodialator responsive test Degree of improvement of air flow in response to bronco dilator Can differentiate Asthma from other COPD But neither asthma nor COPD is diagnosed on spirometry bronchodilator Dose FEV1 before and after Salbutamol 200-400mcg via large spacer 15 min Terbutaline 500 mcg via turbohaler 15 min Ipratropium 160 mcg via spacer 45 min
  • 30. The test can be concluded when both ACCEPTABILITY and REPEATABILITY criteria are met To ensure the REPRODUCIBILITY of the test Requires 5 to maximum 8 attempt
  • 31.  Free from artefact ( Cough / Early glottis closure)  Good start  Free from leaks  Extrapolation back from the PEFR gives a theoretical start time (should be within 5% of FVC or within 150 ml)  Acceptable exhalation  Adults :at least 6 sec of exhalation and plateue  Children <10yrs : at least 3 sec of exhalation
  • 32.  Three acceptable maneuvers (meeting above criteria)  Two largest FVC measurements within 150 ml of each others  Two largest FEV1 measurements within 150ml of each others
  • 33. 1. FVC 2. FEV1 3. FEF 25-75 4. Change in FVC and FEV1 after broncho dialator use 5. Flow volume curve 6. Flow time curve
  • 35.
  • 36.  Total volume of air that can be exhaled forcefully from TLC  The majority of FVC can be exhaled in<3 seconds in normal  Often prolonged in Obstructive lung disease  Measured in liters
  • 37.  80-120% = Normal  70-79% = Mild reduction  50-69% = Moderate reduction  <50% = Severe reduction
  • 38.  Volume of air forcefully expired from full inspiration (TLC) in first second  Normally 75-80% of FVC is exhaled in first second  Thus FEV1/FVC can be utilised to characterise lung disease
  • 39.  Mean forced expiratory flow during middle half of FVC  May reflect effort independent expiration And the status of the small air way
  • 40.
  • 41.  >60% normal  40-60% mild obstruction  20-40% moderate obstruction  <20% Severe obstruction
  • 42. INTERPRETETION FVC alone does not make any sense unless and until we compare it with the time dimension i.e. FEV1 Main determinant of PFT is the FEV1/FVC FEV1/FVC (>80%) LOW Normal/high Always obstructive Restrictive
  • 43. Obstructive 1. COPD (Emphysema/ Bronchiectasis/S AD) 1. ASTHMA 2. CF 3. BRONCHIOLITIS 4. BRONCHIECTASIS For expiration driving force >Air pressure Driving force = IPP + Elastic recoil pressure Elastic recoil pressure is low in obstructive ds That is why exp function (FVC) starts falling day by day Hyperinflation Air trapping FEV1 low Low FVC normal Low RV High High TLC (FVC+RV) High Remain unchanged
  • 45. Q. Can obstr lung dis have normal FEV1/FVC ? Yes, in Small air way disease. Here we diagnose SAD by FEF 25-75 /MMEFR/MEAN FORCED EXPIRATORY FLOW RATE It is the average flow rate of lung in middle 50% of the FVC manouver It is the slope of the line
  • 46.  Reversibility test by SABA  If FEV1 > 12% and FVC > 200ml It indicates Bronchial Asthma
  • 48.
  • 49.  Here lung’s inspiratory function is affected  So IRV is decreased  FVC= IRV + TV +ERV = FVC  FEV1 remains normal more or less  FEV1/FVC remains normal/high
  • 50.
  • 52.  Restrictive Restrictive Extra parenchymal NM disorders (TLC Low Chest wall deformities Intra parenchymal DLCO normal DLCO low KCO normal
  • 53. Intra parenchymal NM disorder Chest wall deformity DLCO LOW NORMAL TLC LOW LOW NORMAL RV LOW NORMAL RV/TLC HIGH NORMAL KCO (DLCO/VOL) NORMAL HIGH
  • 54.  It uses a small amount of CO to measure gas exchange across the alveolar membrane during a 10 sec breath hold.  CO in exhaled air is analysed to determine the quantity of CO crossing the membrane
  • 55. FACTORS INCREASD DLCO DECREASED DLCO Thickness of alveolar membrane ILD smoking Altered volume/surface area ratio Emphysema Hb available Polycythemia Anaemia Pregnancy Blood coming to capilleris Pulmonary Hge Asthma Left to right shunt Exercise Pulmonary vascular disease
  • 56.  Diffusion limited gas  Affinity of Hb for CO is >200 times  Partial pressure of CO in pulmonary capillaries rises very slowly KCO (Diffusion coefficient)= DLCO/ Lung Volume Normal in ILD Raised in Extra parencymal disease
  • 57. Intra parenchymal NM disorder Chest wall deformity DLCO LOW NORMAL TLC LOW LOW NORMAL RV LOW NORMAL RV/TLC HIGH NORMAL KCO (DLCO/VOL) NORMAL HIGH
  • 58. Different flow vol loops NORMAL Scooped pattern Fixed airway obstruction Extra thoracic variable obstruction Intra thoracic variable obstr
  • 60.  Narrowing is maximal in Expiration  As lesion is intra thoracic  Intra thoracic pressure is maximum in expiration and lower than air  Thus expiratory limb is flattened e.g. Tracheomalacia
  • 61.  Obstruction worsens in inspiration  As negative pressure narrows trachea  Thus Inspiratory limb flattens  E.g extrinsic compression from Goiter, LN
  • 62.  Maximum airflow is limited to a similar extent in both inspiration as well as expiration  Both limbs are affected  E.g. Tracheal stenosis, FB
  • 63.  Most common cause is poor patient technique Sub optimal inspiration Sub maximal expiratory effort Delay in forced expiration Shortened expiratory time Air leak around the mouth piece Poor posture = leaning forward Subjects must be observed and encouraged through the procedure
  • 64.
  • 66.  Highly dependent on patient compliance and effort  Thus FEV1 and FVC may be underestimated  Not useful for <4years/unconcious/sedated  Can not measure RV,FRC,TLC